Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Henry Boot predicts brighter future but expects "lag" in performance

(Sharecast News) - UK-listed property developer Henry Boot has said that, while it expects macro conditions to improve this year, the company will see a "lag" in performance with results likely to be weighted to the second half. Chief executive Tim Roberts said "it's beginning to feel as though the UK economy has turned a corner" as recent reductions in mortgage rates precede a fall in the Bank Rate, "pointing towards a hopefully brighter future" as the demand for houses, residential land and commercial property picks up.

"Not surprisingly, we do not have clear visibility on how all of this will unfold and, with key transactions to execute and complete this year in both land promotion and development, we expect 2024 results will be heavily second half weighted," he said. Meanwhile, the time it takes for projects and sales to complete means Henry Boot will see a "lag in performance in the year ahead", he added.

The comments came as the company reported an 18% fall in pre-tax profit as expected to £37.3m. Return on capital employed slumped to 9.9% from 12% and slightly below the medium-term target range of 10-15%.

Revenues, however, increased by 5.3% to £359.4m, driven by land disposals, property development and housing completions.

The company, which reiterated its confidence in achieving medium-term growth and return targets, proposed a final dividend of 4.4p, up 10% on the year before, taking the total dividend to 7.33p, up from 6.66p.

The stock was down 0.7 at 182.75p by 0942 GMT.

Share this article

Related Sharecast Articles

Sirius Real Estate ups dividend as profits jump 32%
(Sharecast News) - Profits at business and industrial parks developer Sirius Real Estate surged by nearly a third in the year ended 31 March, helping the company to increase dividends for the tenth straight year.
GSK to appeal Delaware ruling on jury trials in Zantac cancer cases
(Sharecast News) - Pharma giant GSK said it would be appealing against a US court decision allowing jury trials in cases brought by cancer sufferers claiming its heartburn drug caused their condition.
AstraZeneca's lung cancer treatment recommended for approval in EU
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
China manufacturing PMI ticks up more than expected - Caixin
(Sharecast News) - Activity in China's manufacturing sector grew in May at the fastest rate in two years, according to data released on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.